Depreciation, Depletion and Amortization of Arbutus Biopharma Corp from 31 Mar 2018 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Arbutus Biopharma Corp quarterly Depreciation, Depletion and Amortization in USD history and change rate from 31 Mar 2018 to 31 Mar 2025.
  • Arbutus Biopharma Corp Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $330,000, a 7% decline year-over-year.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Arbutus Biopharma Corp Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $330,000 -$25,000 -7% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $355,000 +$21,000 +6.3% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $334,000 -$60,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $394,000 -$49,000 -11% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $443,000 -$57,000 -11% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $500,000 -$9,000 -1.8% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q3 2019 $507,000 +$10,000 +2% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $505,000 -$73,000 -13% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $509,000 -$93,000 -15% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q3 2018 $497,000 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $578,000 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019 2019 Q2
Q1 2018 $602,000 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.